(Q44781642)

6 December 2017

HBsAg-Serum Protein Complexes Stimulate Immune T Lymphocytes More Efficiently Than Do Pure HBsAg (English)

1 reference

https://api.crossref.org/works/10.1002/HEP.1840040604

4 September 2023

main subject

lymphocyte activation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6238896

4 September 2023

author name string

E. Celis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6238896

4 September 2023

T. W. Chang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6238896

4 September 2023

language of work or name

English

0 references

publication date

1 November 1984

1 reference

full work available at URL

6 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.1840040604

1 reference

https://api.crossref.org/works/10.1002/HEP.1840040604

https://onlinelibrary.wiley.com/doi/full/10.1002/hep.1840040604

4 September 2023

1 reference

https://api.crossref.org/works/10.1002/HEP.1840040604

4 September 2023

1 reference

6 December 2017

4

1 reference

6 December 2017

6

1 reference

6 December 2017

1116-1123

1 reference

Approaching the control of viral hepatitis type B.

6 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

Plasmid-Directed Synthesis of Hepatitis B Surface Antigen in Monkey Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

Inactivated Venezuelan Equine Encephalomyelitis Virus Vaccine Complexed with Specific Antibody: Enhanced Primary Immune Response and Altered Pattern of Antibody Class Elicited

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

Passive-active immunity from hepatitis B immune globulin. Reanalysis of a Veterans Administration cooperative study of needle-stick hepatitis. The Veterans Administration Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Viral hepatitis, type B. Studies on natural history and prevention re-examined

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

T-cell dependence of immune response to hepatitis B antigen in mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Australia Antigen and the Biology of Hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Hepatitis B surface antigen and polymerized albumin binding activity in sheep serum

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Complexes of hepatitis B surface antigen and immunoglobulin M in the sera of patients with hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Hepatitis B and Immune-Complex Disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Antibodies to Hepatitis B Surface Antigen Potentiate the Response of Human T Lymphocyte Clones to the Same Antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Regulation of T-cell function by antibodies: enhancement of the response of human T-cell clones to hepatitis B surface antigen by antigen-specific monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Monoclonal radioimmunoassays for hepatitis B surface antigen: demonstration of hepatitis B virus DNA or related sequences in serum and viral epitopes in immune complexes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

The capacity of murine alveolar macrophages to stimulate antigen-dependent T-lymphocyte activation and proliferation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Persistence of circulating HBsAg/IgM complexes in acute viral hepatitis, type B: an early marker of chronic evolution

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Hepatitis B vaccine: immune responses in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Human hepatitis B vaccine from recombinant yeast

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Excretion of hepatitis B surface antigen particles from mouse cells transformed with cloned viral DNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Synthesis of hepatitis B surface antigen in mammalian cells: expression of the entire gene and the coding region

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Hepatitis B virus vaccine: identification of HBsAg/a and HBsAg/d but not HBsAg/y subtype antigenic determinants on a synthetic immunogenic peptide

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Specificity of antibodies elicited by a synthetic peptide having a sequence in common with a fragment of a virus protein, the hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Passive-active immunisation of neonates of HBsAg positive carrier mothers: preliminary observations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840040604

7 January 2021

Circulating immune complexes in hepatitis B: levels, immunoglobulin class of antibody and the presence of hepatitis B surface antigen

18

1 reference

https://api.crossref.org/works/10.1002/HEP.1840040604

Passive and active immunoprophylaxis of hepatitis B

4 September 2023

60

1 reference

https://api.crossref.org/works/10.1002/HEP.1840040604

4 September 2023

Identifiers

1 reference

6 December 2017

1 reference